Details for: PHGDH

Gene ID: 26227

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: PHGDH

Ensembl ID: ENSG00000092621

Description: phosphoglycerate dehydrogenase

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • intestinal epithelial cell CL0002563
    CSI 26.25
    rCSI 27.43%
    PRS 85.89
  • keratinocyte CL0000312
    CSI 21.81
    rCSI 18.28%
    PRS 89.28
  • fallopian tube secretory epithelial cell CL4030006
    CSI 17.34
    rCSI 16.69%
    PRS 87.04
  • stem cell CL0000034
    CSI 15.6
    rCSI 15.04%
    PRS 83.66
  • respiratory basal cell CL0002633
    CSI 14.88
    rCSI 15.41%
    PRS 90.27
  • epithelial cell of lung CL0000082
    CSI 11.75
    rCSI 9.74%
    PRS 89.28
  • vascular associated smooth muscle cell CL0000359
    CSI 11.04
    rCSI 35.81%
    PRS 86.31
  • forebrain radial glial cell CL0013000
    CSI 11.01
    rCSI 35.32%
    PRS 88.36
  • mesodermal cell CL0000222
    CSI 9.94
    rCSI 11.93%
    PRS 87.03
  • lung secretory cell CL1000272
    CSI 9.91
    rCSI 24.54%
    PRS 88.55
  • colon epithelial cell CL0011108
    CSI 9.07
    rCSI 9.5%
    PRS 85.76
  • ciliated cell CL0000064
    CSI 7.62
    rCSI 12.35%
    PRS 82.65
  • pro-B cell CL0000826
    CSI 6.93
    rCSI 5.74%
    PRS 90.13
  • neural crest cell CL0011012
    CSI 6.05
    rCSI 4.78%
    PRS 80.16
  • pancreatic ductal cell CL0002079
    CSI 6.03
    rCSI 11.73%
    PRS 90
  • transit amplifying cell CL0009010
    CSI 5.86
    rCSI 8.96%
    PRS 92.21
  • plasmablast CL0000980
    CSI 5.61
    rCSI 4.42%
    PRS 91.07
  • glioblast CL0000030
    CSI 5.57
    rCSI 8.89%
    PRS 80.5
  • pancreatic stellate cell CL0002410
    CSI 5.42
    rCSI 31.51%
    PRS 90.16
  • pancreatic acinar cell CL0002064
    CSI 5.2
    rCSI 6.91%
    PRS 91.65
  • myofibroblast cell CL0000186
    CSI 5.1
    rCSI 7.07%
    PRS 84.81
  • placental villous trophoblast CL2000060
    CSI 5.03
    rCSI 7.77%
    PRS 86.83
  • ciliated epithelial cell CL0000067
    CSI 4.94
    rCSI 4.35%
    PRS 79.12
  • melanocyte CL0000148
    CSI 4.93
    rCSI 3.65%
    PRS 83.8
  • ionocyte CL0005006
    CSI 4.83
    rCSI 5.17%
    PRS 89.93
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 4.68
    rCSI 5.41%
    PRS 81.01
  • intestine goblet cell CL0019031
    CSI 4.63
    rCSI 4.11%
    PRS 85.74
  • interneuron CL0000099
    CSI 4.36
    rCSI 8.76%
    PRS 81.38
  • hematopoietic stem cell CL0000037
    CSI 4.18
    rCSI 2.78%
    PRS 90.09
  • large pre-B-II cell CL0000957
    CSI 4.16
    rCSI 11.86%
    PRS 89.92
  • radial glial cell CL0000681
    CSI 3.99
    rCSI 5.54%
    PRS 86.73
  • fibroblast of lung CL0002553
    CSI 3.91
    rCSI 3.64%
    PRS 89.3
  • hepatocyte CL0000182
    CSI 3.88
    rCSI 6.95%
    PRS 87.23
  • early lymphoid progenitor CL0000936
    CSI 3.7
    rCSI 3.25%
    PRS 91.94
  • extravillous trophoblast CL0008036
    CSI 3.46
    rCSI 4.28%
    PRS 86.75
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 3.39
    rCSI 3.06%
    PRS 87.08
  • interstitial cell of Cajal CL0002088
    CSI 3.34
    rCSI 4.25%
    PRS 92.27
  • skin fibroblast CL0002620
    CSI 3.26
    rCSI 2.81%
    PRS 87.8
  • neural progenitor cell CL0011020
    CSI 3.24
    rCSI 14.27%
    PRS 77.24
  • goblet cell CL0000160
    CSI 3.22
    rCSI 3.04%
    PRS 86.13
  • enteroendocrine cell CL0000164
    CSI 3.15
    rCSI 4.3%
    PRS 87.04
  • IgA plasma cell CL0000987
    CSI 3.09
    rCSI 3.16%
    PRS 91.25
  • epithelial cell CL0000066
    CSI 3.08
    rCSI 4.73%
    PRS 76.82
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 3.02
    rCSI 4.29%
    PRS 85.67
  • common myeloid progenitor CL0000049
    CSI 3.02
    rCSI 2.44%
    PRS 89.94
  • Bergmann glial cell CL0000644
    CSI 3.01
    rCSI 4.12%
    PRS 80.25
  • perivascular cell CL4033054
    CSI 3.01
    rCSI 4.12%
    PRS 91.58
  • mucus secreting cell CL0000319
    CSI 2.89
    rCSI 4.59%
    PRS 93.32
  • epithelial cell of proximal tubule CL0002306
    CSI 2.74
    rCSI 6.69%
    PRS 81.27
  • common dendritic progenitor CL0001029
    CSI 2.73
    rCSI 3.43%
    PRS 93.85
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 2.72
    rCSI 3.49%
    PRS 84.77
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 2.71
    rCSI 5.13%
    PRS 94.15
  • peripheral nervous system neuron CL2000032
    CSI 2.71
    rCSI 3.7%
    PRS 81.58
  • bronchus fibroblast of lung CL2000093
    CSI 2.68
    rCSI 2.18%
    PRS 87.6
  • alveolar adventitial fibroblast CL4028006
    CSI 2.65
    rCSI 4.18%
    PRS 89.07
  • granulocyte monocyte progenitor cell CL0000557
    CSI 2.63
    rCSI 2.28%
    PRS 90.8
  • mucous neck cell CL0000651
    CSI 2.63
    rCSI 3.79%
    PRS 91.66
  • choroid plexus epithelial cell CL0000706
    CSI 2.63
    rCSI 4.31%
    PRS 80.23
  • acinar cell CL0000622
    CSI 2.6
    rCSI 3.81%
    PRS 94.07
  • pancreatic A cell CL0000171
    CSI 2.56
    rCSI 2.68%
    PRS 90.38
  • myoepithelial cell CL0000185
    CSI 2.49
    rCSI 6.3%
    PRS 91.25
  • Schwann cell CL0002573
    CSI 2.48
    rCSI 7.06%
    PRS 84.28
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.47
    rCSI 2.51%
    PRS 94.03
  • conjunctival epithelial cell CL1000432
    CSI 2.46
    rCSI 3.75%
    PRS 87.53
  • enteric smooth muscle cell CL0002504
    CSI 2.4
    rCSI 3.42%
    PRS 88.62
  • M cell of gut CL0000682
    CSI 2.39
    rCSI 2.54%
    PRS 90.72
  • adventitial cell CL0002503
    CSI 2.38
    rCSI 5.69%
    PRS 90.63
  • astrocyte of the cerebral cortex CL0002605
    CSI 2.26
    rCSI 5.07%
    PRS 74.44
  • basal cell CL0000646
    CSI 2.24
    rCSI 2.99%
    PRS 85.59
  • duct epithelial cell CL0000068
    CSI 2.14
    rCSI 3.13%
    PRS 91.94
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 2.13
    rCSI 3.87%
    PRS 81.36
  • kidney epithelial cell CL0002518
    CSI 2.12
    rCSI 4.06%
    PRS 95.77
  • stromal cell CL0000499
    CSI 2.1
    rCSI 5.91%
    PRS 83.99
  • lung ciliated cell CL1000271
    CSI 2.08
    rCSI 2.4%
    PRS 82.22
  • retinal pigment epithelial cell CL0002586
    CSI 2.05
    rCSI 4.06%
    PRS 84.44
  • chondrocyte CL0000138
    CSI 2
    rCSI 3.19%
    PRS 83.04
  • periportal region hepatocyte CL0019026
    CSI 1.94
    rCSI 7.53%
    PRS 85.8
  • fraction A pre-pro B cell CL0002045
    CSI 1.89
    rCSI 2.16%
    PRS 93.61
  • hair follicular keratinocyte CL2000092
    CSI 1.81
    rCSI 31.56%
    PRS 92.41
  • enterocyte CL0000584
    CSI 1.81
    rCSI 2.92%
    PRS 85.41
  • multi-ciliated epithelial cell CL0005012
    CSI 1.76
    rCSI 1.76%
    PRS 82.55
  • keratocyte CL0002363
    CSI 1.76
    rCSI 4.22%
    PRS 89.54
  • promyelocyte CL0000836
    CSI 1.7
    rCSI 2.46%
    PRS 91.29
  • IgG plasma cell CL0000985
    CSI 1.64
    rCSI 1.97%
    PRS 93.39
  • promonocyte CL0000559
    CSI 1.59
    rCSI 2.72%
    PRS 91.2
  • mesenchymal cell CL0008019
    CSI 1.56
    rCSI 3.97%
    PRS 82.85
  • mammary gland epithelial cell CL0002327
    CSI 1.54
    rCSI 5.4%
    PRS 92.83
  • club cell CL0000158
    CSI 1.53
    rCSI 2.24%
    PRS 83.5
  • glial cell CL0000125
    CSI 1.52
    rCSI 5.77%
    PRS 81.07
  • pluripotent stem cell CL0002248
    CSI 1.51
    rCSI 45.3%
    PRS 93.84
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 1.34
    rCSI 2.37%
    PRS 73.32
  • acinar cell of salivary gland CL0002623
    CSI 1.14
    rCSI 26.48%
    PRS 94.48
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 1.09
    rCSI 4.25%
    PRS 97.04
  • germinal center B cell CL0000844
    CSI 1.06
    rCSI 3.16%
    PRS 93.07
  • epithelial cell of nephron CL1000449
    CSI 1
    rCSI 9.45%
    PRS 97.23
  • luminal cell of prostate epithelium CL0002340
    CSI 0.95
    rCSI 5.1%
    PRS 92.84
  • tracheobronchial serous cell CL0019001
    CSI 0.94
    rCSI 4.05%
    PRS 91.49
  • syncytiotrophoblast cell CL0000525
    CSI 0.92
    rCSI 2.65%
    PRS 90.48
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 0.87
    rCSI 4.48%
    PRS 96.7
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 0.84
    rCSI 1.92%
    PRS 81.37
  • mesenchymal lymphangioblast CL0005021
    CSI 0.2
    rCSI 5.9%
    PRS 92.3%
  • peptic cell CL0000155
    CSI 0.3
    rCSI 3.4%
    PRS 93.4%
  • epithelial cell of esophagus CL0002252
    CSI 0.4
    rCSI 3.9%
    PRS 88.7%
  • mesenchymal stem cell CL0000134
    CSI 0.8
    rCSI 8.3%
    PRS 90.7%
  • stromal cell of ovary CL0002132
    CSI 0.8
    rCSI 2.2%
    PRS 91.9%
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 0.8
    rCSI 1.9%
    PRS 81.4%
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 0.9
    rCSI 4.5%
    PRS 96.7%
  • syncytiotrophoblast cell CL0000525
    CSI 0.9
    rCSI 2.7%
    PRS 90.5%
  • tracheobronchial serous cell CL0019001
    CSI 0.9
    rCSI 4.1%
    PRS 91.5%
  • luminal cell of prostate epithelium CL0002340
    CSI 1.0
    rCSI 5.1%
    PRS 92.8%
  • epithelial cell of nephron CL1000449
    CSI 1.0
    rCSI 9.5%
    PRS 97.2%
  • germinal center B cell CL0000844
    CSI 1.1
    rCSI 3.2%
    PRS 93.1%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 1.1
    rCSI 4.3%
    PRS 97.0%
  • acinar cell of salivary gland CL0002623
    CSI 1.1
    rCSI 26.5%
    PRS 94.5%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 1.3
    rCSI 2.4%
    PRS 73.3%
  • pluripotent stem cell CL0002248
    CSI 1.5
    rCSI 45.3%
    PRS 93.8%
  • glial cell CL0000125
    CSI 1.5
    rCSI 5.8%
    PRS 81.1%
  • club cell CL0000158
    CSI 1.5
    rCSI 2.2%
    PRS 83.5%
  • mammary gland epithelial cell CL0002327
    CSI 1.5
    rCSI 5.4%
    PRS 92.8%
  • mesenchymal cell CL0008019
    CSI 1.6
    rCSI 4.0%
    PRS 82.9%
  • promonocyte CL0000559
    CSI 1.6
    rCSI 2.7%
    PRS 91.2%
  • IgG plasma cell CL0000985
    CSI 1.6
    rCSI 2.0%
    PRS 93.4%
  • promyelocyte CL0000836
    CSI 1.7
    rCSI 2.5%
    PRS 91.3%
  • keratocyte CL0002363
    CSI 1.8
    rCSI 4.2%
    PRS 89.5%
  • multi-ciliated epithelial cell CL0005012
    CSI 1.8
    rCSI 1.8%
    PRS 82.6%
  • enterocyte CL0000584
    CSI 1.8
    rCSI 2.9%
    PRS 85.4%
  • hair follicular keratinocyte CL2000092
    CSI 1.8
    rCSI 31.6%
    PRS 92.4%
  • fraction A pre-pro B cell CL0002045
    CSI 1.9
    rCSI 2.2%
    PRS 93.6%
  • periportal region hepatocyte CL0019026
    CSI 1.9
    rCSI 7.5%
    PRS 85.8%
  • chondrocyte CL0000138
    CSI 2.0
    rCSI 3.2%
    PRS 83.0%
  • retinal pigment epithelial cell CL0002586
    CSI 2.1
    rCSI 4.1%
    PRS 84.4%
  • lung ciliated cell CL1000271
    CSI 2.1
    rCSI 2.4%
    PRS 82.2%
  • stromal cell CL0000499
    CSI 2.1
    rCSI 5.9%
    PRS 84.0%
  • kidney epithelial cell CL0002518
    CSI 2.1
    rCSI 4.1%
    PRS 95.8%
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 2.1
    rCSI 3.9%
    PRS 81.4%
  • duct epithelial cell CL0000068
    CSI 2.1
    rCSI 3.1%
    PRS 91.9%
  • basal cell CL0000646
    CSI 2.2
    rCSI 3.0%
    PRS 85.6%
  • astrocyte of the cerebral cortex CL0002605
    CSI 2.3
    rCSI 5.1%
    PRS 74.4%
  • adventitial cell CL0002503
    CSI 2.4
    rCSI 5.7%
    PRS 90.6%
  • M cell of gut CL0000682
    CSI 2.4
    rCSI 2.5%
    PRS 90.7%
  • enteric smooth muscle cell CL0002504
    CSI 2.4
    rCSI 3.4%
    PRS 88.6%
  • conjunctival epithelial cell CL1000432
    CSI 2.5
    rCSI 3.8%
    PRS 87.5%
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.5
    rCSI 2.5%
    PRS 94.0%
  • Schwann cell CL0002573
    CSI 2.5
    rCSI 7.1%
    PRS 84.3%
  • myoepithelial cell CL0000185
    CSI 2.5
    rCSI 6.3%
    PRS 91.3%
  • pancreatic A cell CL0000171
    CSI 2.6
    rCSI 2.7%
    PRS 90.4%
  • acinar cell CL0000622
    CSI 2.6
    rCSI 3.8%
    PRS 94.1%
  • choroid plexus epithelial cell CL0000706
    CSI 2.6
    rCSI 4.3%
    PRS 80.2%
  • mucous neck cell CL0000651
    CSI 2.6
    rCSI 3.8%
    PRS 91.7%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 2.6
    rCSI 2.3%
    PRS 90.8%
  • alveolar adventitial fibroblast CL4028006
    CSI 2.7
    rCSI 4.2%
    PRS 89.1%
  • bronchus fibroblast of lung CL2000093
    CSI 2.7
    rCSI 2.2%
    PRS 87.6%
  • peripheral nervous system neuron CL2000032
    CSI 2.7
    rCSI 3.7%
    PRS 81.6%
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 2.7
    rCSI 5.1%
    PRS 94.2%
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 2.7
    rCSI 3.5%
    PRS 84.8%
  • common dendritic progenitor CL0001029
    CSI 2.7
    rCSI 3.4%
    PRS 93.9%
  • epithelial cell of proximal tubule CL0002306
    CSI 2.7
    rCSI 6.7%
    PRS 81.3%
  • mucus secreting cell CL0000319
    CSI 2.9
    rCSI 4.6%
    PRS 93.3%
  • perivascular cell CL4033054
    CSI 3.0
    rCSI 4.1%
    PRS 91.6%
  • Bergmann glial cell CL0000644
    CSI 3.0
    rCSI 4.1%
    PRS 80.3%
  • common myeloid progenitor CL0000049
    CSI 3.0
    rCSI 2.4%
    PRS 89.9%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 3.0
    rCSI 4.3%
    PRS 85.7%
  • epithelial cell CL0000066
    CSI 3.1
    rCSI 4.7%
    PRS 76.8%
  • IgA plasma cell CL0000987
    CSI 3.1
    rCSI 3.2%
    PRS 91.3%
  • enteroendocrine cell CL0000164
    CSI 3.2
    rCSI 4.3%
    PRS 87.0%
  • goblet cell CL0000160
    CSI 3.2
    rCSI 3.0%
    PRS 86.1%
  • neural progenitor cell CL0011020
    CSI 3.2
    rCSI 14.3%
    PRS 77.2%
  • skin fibroblast CL0002620
    CSI 3.3
    rCSI 2.8%
    PRS 87.8%
  • interstitial cell of Cajal CL0002088
    CSI 3.3
    rCSI 4.3%
    PRS 92.3%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 3.4
    rCSI 3.1%
    PRS 87.1%
  • extravillous trophoblast CL0008036
    CSI 3.5
    rCSI 4.3%
    PRS 86.8%
  • early lymphoid progenitor CL0000936
    CSI 3.7
    rCSI 3.3%
    PRS 91.9%
  • hepatocyte CL0000182
    CSI 3.9
    rCSI 7.0%
    PRS 87.2%
  • fibroblast of lung CL0002553
    CSI 3.9
    rCSI 3.6%
    PRS 89.3%
  • radial glial cell CL0000681
    CSI 4.0
    rCSI 5.5%
    PRS 86.7%
  • large pre-B-II cell CL0000957
    CSI 4.2
    rCSI 11.9%
    PRS 89.9%
  • hematopoietic stem cell CL0000037
    CSI 4.2
    rCSI 2.8%
    PRS 90.1%
  • interneuron CL0000099
    CSI 4.4
    rCSI 8.8%
    PRS 81.4%
  • intestine goblet cell CL0019031
    CSI 4.6
    rCSI 4.1%
    PRS 85.7%
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 4.7
    rCSI 5.4%
    PRS 81.0%
  • ionocyte CL0005006
    CSI 4.8
    rCSI 5.2%
    PRS 89.9%
  • melanocyte CL0000148
    CSI 4.9
    rCSI 3.7%
    PRS 83.8%
  • ciliated epithelial cell CL0000067
    CSI 4.9
    rCSI 4.4%
    PRS 79.1%
  • placental villous trophoblast CL2000060
    CSI 5.0
    rCSI 7.8%
    PRS 86.8%
  • myofibroblast cell CL0000186
    CSI 5.1
    rCSI 7.1%
    PRS 84.8%
  • pancreatic acinar cell CL0002064
    CSI 5.2
    rCSI 6.9%
    PRS 91.7%
  • pancreatic stellate cell CL0002410
    CSI 5.4
    rCSI 31.5%
    PRS 90.2%
  • glioblast CL0000030
    CSI 5.6
    rCSI 8.9%
    PRS 80.5%
  • plasmablast CL0000980
    CSI 5.6
    rCSI 4.4%
    PRS 91.1%
  • transit amplifying cell CL0009010
    CSI 5.9
    rCSI 9.0%
    PRS 92.2%
  • pancreatic ductal cell CL0002079
    CSI 6.0
    rCSI 11.7%
    PRS 90.0%
  • neural crest cell CL0011012
    CSI 6.1
    rCSI 4.8%
    PRS 80.2%
  • pro-B cell CL0000826
    CSI 6.9
    rCSI 5.7%
    PRS 90.1%
  • ciliated cell CL0000064
    CSI 7.6
    rCSI 12.4%
    PRS 82.7%
  • colon epithelial cell CL0011108
    CSI 9.1
    rCSI 9.5%
    PRS 85.8%
  • lung secretory cell CL1000272
    CSI 9.9
    rCSI 24.5%
    PRS 88.6%
  • mesodermal cell CL0000222
    CSI 9.9
    rCSI 11.9%
    PRS 87.0%
  • forebrain radial glial cell CL0013000
    CSI 11.0
    rCSI 35.3%
    PRS 88.4%
  • vascular associated smooth muscle cell CL0000359
    CSI 11.0
    rCSI 35.8%
    PRS 86.3%
  • epithelial cell of lung CL0000082
    CSI 11.8
    rCSI 9.7%
    PRS 89.3%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [PHGDH](/details-gene/26227) (phosphoglycerate dehydrogenase) is the gene encoding the enzyme that catalyzes the first, rate-limiting step in the de novo L-serine biosynthesis pathway. This process is crucial for providing precursors for the synthesis of proteins, nucleotides, and lipids, thereby supporting cellular proliferation and growth. Reflecting this fundamental metabolic role, [PHGDH](/details-gene/26227) shows significant expression in highly proliferative and metabolically active cell types, including [intestinal epithelial cell](/details-cell/CL0002563)s and [keratinocyte](/details-cell/CL0000312)s. Clinically, mutations in [PHGDH](/details-gene/26227) are associated with severe neurometabolic disorders characterized by congenital microcephaly and psychomotor retardation ([OMIM: 601815](https://omim.org/entry/601815)), underscoring its essential function in neural development ([Link](https://doi.org/10.1086/316886)). ## Cellular Roles and Expression Landscape The expression profile of [PHGDH](/details-gene/26227) highlights its central role in tissues with high rates of cell turnover and biosynthetic activity. **Overall**, its significance is highest in various epithelial lineages responsible for barrier function and regeneration. It is a top marker for [intestinal epithelial cell](/details-cell/CL0002563) (CSI: 26.25), [keratinocyte](/details-cell/CL0000312) (CSI: 21.81), and [fallopian tube secretory epithelial cell](/details-cell/CL4030006) (CSI: 17.34), consistent with the high metabolic demands of these rapidly dividing cell populations. Furthermore, [PHGDH](/details-gene/26227) is significantly expressed in stem and progenitor cell populations, suggesting a role in development and tissue maintenance. This includes high significance in [stem cell](/details-cell/CL0000034)s (CSI: 15.60), [respiratory basal cell](/details-cell/CL0002633)s (CSI: 14.88), and [forebrain radial glial cell](/details-cell/CL0013000)s (CSI: 11.01). This pattern aligns with its known function in providing the building blocks necessary for cell division and differentiation during organogenesis and homeostasis. Its expression in [vascular associated smooth muscle cell](/details-cell/CL0000359) (CSI: 11.04) also points to a role in maintaining vascular tissue integrity. ## Pathways and Molecular Function Functionally, [PHGDH](/details-gene/26227) is a cytosolic enzyme whose primary molecular function is [Phosphoglycerate dehydrogenase activity](/details-ontology/GO:0004617), which involves NAD binding ([GO:0051287](https://www.ebi.ac.uk/QuickGO/term/GO:0051287)). This activity is the committed step in the [Serine biosynthesis](/details-pathway/R-HSA-977347) pathway ([GO:0006564](https://www.ebi.ac.uk/QuickGO/term/GO:0006564)), a critical branch of the broader [Metabolism of amino acids and derivatives](/details-pathway/R-HSA-71291). The L-serine produced via this pathway is not only a component of proteins but also a precursor for other amino acids like glycine and cysteine, as well as phospholipids and purines. The importance of this pathway is particularly evident in the central nervous system, where [PHGDH](/details-gene/26227) is implicated in biological processes such as [Brain development](/details-ontology/GO:0007420), [Neural tube development](/details-ontology/GO:0021915), and [Neuron projection development](/details-ontology/GO:0031175). Deficiencies in the enzyme disrupt these processes, leading to severe neurological conditions ([Link](https://doi.org/10.1086/316886)). Additionally, research has shown that [PHGDH](/details-gene/26227) can produce the oncometabolite D-2-hydroxyglutarate, implicating it in cancer metabolism ([Link](https://doi.org/10.1021/cb500683c)). ## Research Directions The role of [PHGDH](/details-gene/26227) in fueling cell proliferation is well-established, but its specific contributions to pathology, particularly in cancer, remain an active area of investigation. Its high expression in rapidly dividing normal tissues alongside its upregulation in various cancers presents a classic therapeutic challenge. Based on the available data, several testable hypotheses can be proposed: 1. Given its high expression in epithelial tissues, inhibition of [PHGDH](/details-gene/26227) will disproportionately affect the growth and survival of epithelial-derived cancers (e.g., colorectal, skin, and breast cancers) compared to cancers of other origins by creating a state of serine auxotrophy. 2. The production of D-2-hydroxyglutarate by [PHGDH](/details-gene/26227) is context-dependent and may be enhanced under specific metabolic conditions (e.g., hypoxia or high glutamine availability), contributing to epigenetic dysregulation and tumorigenesis in a subset of cancers that do not have canonical IDH1/2 mutations. A key experiment to test the first hypothesis would be to use a panel of cancer cell lines from both epithelial (e.g., colorectal adenocarcinoma, melanoma) and non-epithelial (e.g., leukemia, sarcoma) origins. These cell lines could be treated with a specific small-molecule inhibitor of [PHGDH](/details-gene/26227). The experimental readout would involve measuring cell viability and proliferation rates, alongside metabolomic profiling to confirm the depletion of the serine/glycine pool and its downstream effects on nucleotide and glutathione synthesis. This would help determine if the tissue of origin predicts sensitivity to [PHGDH](/details-gene/26227) inhibition. As a therapeutic target, [PHGDH](/details-gene/26227) is a compelling candidate for **inhibition** in oncology. Its enzymatic nature makes it amenable to small-molecule drug development. However, a significant challenge is the potential for on-target toxicity in highly proliferative normal tissues, such as the intestinal lining and skin, which also rely on its function. A successful therapeutic strategy may require intermittent dosing schedules or combination therapies to mitigate side effects while effectively targeting the metabolic vulnerability of cancer cells.

Genular Protein ID: 3790902606

Symbol: SERA_HUMAN

Name: D-3-phosphoglycerate dehydrogenase

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 10713460

Title: Nucleotide sequence and differential expression of the human 3-phosphoglycerate dehydrogenase gene.

PubMed ID: 10713460

DOI: 10.1016/s0378-1119(00)00009-3

PubMed ID: 11055895

Title: Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency -- a neurometabolic disorder associated with reduced L-serine biosynthesis.

PubMed ID: 11055895

DOI: 10.1086/316886

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 16710414

Title: The DNA sequence and biological annotation of human chromosome 1.

PubMed ID: 16710414

DOI: 10.1038/nature04727

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 11751922

Title: V490M, a common mutation in 3-phosphoglycerate dehydrogenase deficiency, causes enzyme deficiency by decreasing the yield of mature enzyme.

PubMed ID: 11751922

DOI: 10.1074/jbc.m111419200

PubMed ID: 14654843

Title: Proteomic characterization of the human centrosome by protein correlation profiling.

PubMed ID: 14654843

DOI: 10.1038/nature02166

PubMed ID: 16949628

Title: Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells.

PubMed ID: 16949628

DOI: 10.1016/j.steroids.2006.07.006

PubMed ID: 18378410

Title: Positive regulation of promoter activity of human 3-phosphoglycerate dehydrogenase (PHGDH) gene is mediated by transcription factors Sp1 and NF-Y.

PubMed ID: 18378410

DOI: 10.1016/j.gene.2008.02.018

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 25114211

Title: Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.

PubMed ID: 25114211

DOI: 10.1073/pnas.1413825111

PubMed ID: 25406093

Title: Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate.

PubMed ID: 25406093

DOI: 10.1021/cb500683c

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 19235232

Title: Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics.

PubMed ID: 19235232

DOI: 10.1002/humu.20934

PubMed ID: 24836451

Title: Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH.

PubMed ID: 24836451

DOI: 10.1016/j.ajhg.2014.04.015

Sequence Information:

  • Length: 533
  • Mass: 56651
  • Checksum: C58EB72275C45B35
  • Sequence:
  • MAFANLRKVL ISDSLDPCCR KILQDGGLQV VEKQNLSKEE LIAELQDCEG LIVRSATKVT 
    ADVINAAEKL QVVGRAGTGV DNVDLEAATR KGILVMNTPN GNSLSAAELT CGMIMCLARQ 
    IPQATASMKD GKWERKKFMG TELNGKTLGI LGLGRIGREV ATRMQSFGMK TIGYDPIISP 
    EVSASFGVQQ LPLEEIWPLC DFITVHTPLL PSTTGLLNDN TFAQCKKGVR VVNCARGGIV 
    DEGALLRALQ SGQCAGAALD VFTEEPPRDR ALVDHENVIS CPHLGASTKE AQSRCGEEIA 
    VQFVDMVKGK SLTGVVNAQA LTSAFSPHTK PWIGLAEALG TLMRAWAGSP KGTIQVITQG 
    TSLKNAGNCL SPAVIVGLLK EASKQADVNL VNAKLLVKEA GLNVTTSHSP AAPGEQGFGE 
    CLLAVALAGA PYQAVGLVQG TTPVLQGLNG AVFRPEVPLR RDLPLLLFRT QTSDPAMLPT 
    MIGLLAEAGV RLLSYQTSLV SDGETWHVMG ISSLLPSLEA WKQHVTEAFQ FHF